Financial Year |
March 31 2023 |
Monetary Funds |
4,031,497,341.79 |
Held-for-trading Financial Assets |
84,020,000.00 |
Notes Receivable |
10,397,000.00 |
Accounts Receivable |
5,160,353,519.30 |
Advances to Suppliers |
1,643,674,140.34 |
Other Receivables |
703,627,643.36 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,979,721,365.99 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
266,540,518.91 |
Other Current Assets |
1,014,389,505.85 |
Total Current Assets |
17,960,678,939.77 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
77,594,616.95 |
Long-term Equity Investment |
879,649,077.39 |
Investment Properties |
-- |
Fixed Assetes |
805,492,089.48 |
Under-construction Projects |
80,008,920.59 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
3,309,270.00 |
Oil and Gas Assets |
-- |
Intangible Assets |
2,225,494,834.91 |
R&D expenses |
-- |
Goodwill |
1,546,626.02 |
Long-Term Deferred and Prepaid Expenses |
54,875,956.07 |
Deferred Income Tax Assets |
35,726,220.21 |
Other Non-Current Assets |
9,330,255,547.03 |
Sub-Total of Non-Current Assets |
13,637,382,118.31 |
Total Assets |
31,598,061,058.08 |
Short-Term Loans |
2,389,062,917.85 |
Trading Financial liabilities |
-- |
Notes Payable |
1,840,680,359.44 |
Accounts Payable |
5,884,150,485.12 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
125,574,559.58 |
Taxes Payable |
45,472,473.74 |
Interest Payable |
-- |
Dividend Payable |
735,718.99 |
Other payables |
398,677,985.47 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,919,791,559.70 |
Other Current Liabilities |
1,176,795,222.73 |
Sub-Total of Current Liabilities |
17,331,414,779.20 |
Long-term Loans |
9,411,985,572.71 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
530,361,933.51 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
9,949,450,164.42 |
Total Liabilities |
27,280,864,943.62 |
Paid-In Capital(Or Share Stock) |
1,014,902,546.00 |
Capital Surplus |
134,942,162.52 |
Surplus Reserve |
67,272,356.58 |
LESS:Treasury Stock |
14,701,470.00 |
Undistributed Profits |
1,278,962,133.19 |
Minority Stockholder's Interest |
1,836,408,134.58 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,480,787,979.88 |
Owner's Equity(Stockholder's Equity) |
4,317,196,114.46 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
31,598,061,058.08 |